
Company Info
Year Established2012
Contacts
John J. PuisisFounder & CEO
Dannielle Appelhans
COO
Brian Bock
CFO
Roy First, MD
CMO
Company Description
COUR Pharmaceuticals is a clinical-stage biotechnology company developing therapies to treat patients with autoimmune and inflammatory diseases.